Form 4 for TSHA Taysha Gene Therapies, Inc.
Accepted 2023-08-16 00:00:00 ET · period of report 2023-08-16 · accession 0001209191-23-046152 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-08-16 | 2023-08-16 | TSHA | Stalfort John A III | Dir | P - Purchase | $0.9 | +388.9K | 884.3K | +78% | +$350.0K |
| 2023-08-16 | 2023-08-16 | TSHA | Stalfort John A III | Dir | P - Purchase | $0.9 | +388.9K | 999.4K | +64% | +$350.0K | |
| 2023-08-16 | 2023-08-16 | TSHA | Stalfort John A III | Dir | G - Gift | $0.00 | +50.0K | 1.05M | +5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-16 | P | A | 388,889 | $0.9 | 884,290 | I See footnote | — | — | (F1) The securities are held by Gineane Holly Stalfort, as Trustee of the John A. Stalfort III 2018 Irrevocable Trust under agreement dated as of October 25, 2018. |
| 2 | Common | Common Stock | 2023-08-16 | P | A | 388,889 | $0.9 | 999,381 | D | — | — | |
| 3 | Common | Common Stock | 2023-08-16 | G | A | 50,000 | $0.00 | 1,049,381 | D | — | — |